Ekso Bionics Revenue Beats Q3 Estimates Despite Reported Net Loss

Key Facts

1Ekso Bionics reported a GAAP EPS of -$0.29 for the quarter.

2Company revenue reached $41.5M, beating analyst estimates by $23.4M.

Ekso Bionics Holdings reported revenue of $41.5 million for the third quarter of 2026, exceeding analyst estimates by $23.4 million. Seeking Alpha reported that the company posted a GAAP loss per share of $0.29 for the fiscal quarter.

The medical device company's financial results highlighted a significant revenue beat compared to market expectations, suggesting strong operational momentum despite the reported net loss. This performance comes amid a broader economic context where U.S. consumer sentiment was recently pressured, with the Michigan Consumer Sentiment index reaching 46.3 on October 9, 2026.